NCT05500898View on ClinicalTrials.gov

Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults

PHASE1UnknownINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

August 26, 2022

Primary Completion Date

October 31, 2022

Study Completion Date

February 28, 2023

Conditions
Healthy
Interventions
DRUG

DWP16001

Tablets, Oral, multiple doses of DWP16001

DRUG

DWC202204+DWC202205

Tablets, Oral, multiple doses of DWC202204 and DWC202205 in combination

DRUG

DWP16001+DWC202204+DWC202205

Tablets, Oral, DWP16001 , multiple doses of DWC202204 and DWC202205 in combination

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY